First phase I trial of DCVax-Brain in patients with glioblastoma
Phase of Trial: Phase I
Latest Information Update: 03 Aug 2010
At a glance
- Drugs Dendritic cell vaccine-Northwest Biotherapeutics (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Northwest Biotherapeutics
- 03 Aug 2010 Follow-up data from pooled phase I and II trials reported in a Northwest Biotherapeutics media release.
- 05 Nov 2009 New trial record.
- 21 Oct 2009 Further follow-up data reported in a Northwest Biotherapeutics media release.